Correlation Between CREO MEDICAL and Q2M Managementberatu

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CREO MEDICAL and Q2M Managementberatu at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CREO MEDICAL and Q2M Managementberatu into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CREO MEDICAL GRP and Q2M Managementberatung AG, you can compare the effects of market volatilities on CREO MEDICAL and Q2M Managementberatu and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CREO MEDICAL with a short position of Q2M Managementberatu. Check out your portfolio center. Please also check ongoing floating volatility patterns of CREO MEDICAL and Q2M Managementberatu.

Diversification Opportunities for CREO MEDICAL and Q2M Managementberatu

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between CREO and Q2M is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding CREO MEDICAL GRP and Q2M Managementberatung AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Q2M Managementberatung and CREO MEDICAL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CREO MEDICAL GRP are associated (or correlated) with Q2M Managementberatu. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Q2M Managementberatung has no effect on the direction of CREO MEDICAL i.e., CREO MEDICAL and Q2M Managementberatu go up and down completely randomly.

Pair Corralation between CREO MEDICAL and Q2M Managementberatu

Assuming the 90 days horizon CREO MEDICAL GRP is expected to under-perform the Q2M Managementberatu. In addition to that, CREO MEDICAL is 7.13 times more volatile than Q2M Managementberatung AG. It trades about -0.05 of its total potential returns per unit of risk. Q2M Managementberatung AG is currently generating about -0.04 per unit of volatility. If you would invest  95.00  in Q2M Managementberatung AG on October 17, 2024 and sell it today you would lose (5.00) from holding Q2M Managementberatung AG or give up 5.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

CREO MEDICAL GRP  vs.  Q2M Managementberatung AG

 Performance 
       Timeline  
CREO MEDICAL GRP 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CREO MEDICAL GRP has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Q2M Managementberatung 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Q2M Managementberatung AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's forward indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

CREO MEDICAL and Q2M Managementberatu Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CREO MEDICAL and Q2M Managementberatu

The main advantage of trading using opposite CREO MEDICAL and Q2M Managementberatu positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CREO MEDICAL position performs unexpectedly, Q2M Managementberatu can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Q2M Managementberatu will offset losses from the drop in Q2M Managementberatu's long position.
The idea behind CREO MEDICAL GRP and Q2M Managementberatung AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.